FIELD: medicine.
SUBSTANCE: invention relates to field of medical diagnostics and is intended for prediction of risk of development of myomatous nodes of large sizes in patients with myoma. Separation of DNA from peripheral venous blood and analysis of polymorphous versions of genes rs2107538 RANTES, rs1801157 SDF1 and rs16944 IL-1β is performed from women born in Central Chernozem region of Russia of Russian nationality by method of polymerase chain reaction. In case of determination of combination of genotypes GG SDF1, CC IL-1β and AA RANTES increased risk of development of myomatous nodes of large sizes is predicted.
EFFECT: invention ensures obtaining novel criteria of evaluating risk of development of myomatous nodes of large sizes over 4 cm on the base of data about genotypes.
4 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING DEVELOPMENT OF PRE-ECLAMPSIA IN WOMEN WITH NON-BURDENED HEREDITY | 2014 |
|
RU2568893C1 |
METHOD OF PREDICTING DEVELOPMENT OF RISK OF COMBINED PROLIFERATIVE REPRODUCTIVE SYSTEM DISEASES IN WOMEN | 2014 |
|
RU2557954C1 |
METHOD OF PREDICTING SEVERE PRE-ECLAMPSIA | 2014 |
|
RU2568892C1 |
METHOD FOR PREDICTION OF RISK OF ENDOMETRIOSIS | 2014 |
|
RU2558854C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH NORMAL BODY WEIGHT | 2024 |
|
RU2834521C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING COMBINATION OF UTERINE FIBROIDS AND ADENOMYOSIS USING GENETIC DATA | 2018 |
|
RU2677866C1 |
METHOD FOR PREDICTION OF RISK OF GENITAL ENDOMETRIOSIS | 2017 |
|
RU2650994C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA USING MOLECULAR GENETIC DATA | 2024 |
|
RU2834523C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING UTERINE MYOMA BASED ON MOLECULAR GENETIC TESTING | 2024 |
|
RU2833106C1 |
METHOD FOR PREDICTION OF RISK OF PREECLAMPSIA BY COMBINATION OF CYTOKINE GENES | 2014 |
|
RU2568891C1 |
Authors
Dates
2017-04-13—Published
2016-02-01—Filed